Orange, Purple, and the Drugs Between Them
Manage episode 418820004 series 2955001
Panelists will discuss hot topics related to Hatch-Waxman and biosimilar litigation, including recent scrutiny from the FTC over what patents may be listed in the Orange Book.
Questions? Inquiries about program materials? Contact Trenon Browne at tbrowne@bostonbar.org
427 afleveringen